IPL 2021: COVID-19 surge in India raises concern, early exits; BCCI says league will go on
• 4 years agoRavichandran Ashwin and some Australian players have withdrawn from IPL 2021 amid the escalating COVID-19 crisis in India.
India tackled border dispute with China with 'firmness and maturity' amid COVID-19 crisis, says foreign secy
• 4 years agoSpeaking at a leading think-tank in Paris, Harsh Vardhan Shringla on Thursday condemned the recent terror attacks in France, including the one in Nice
India's COVID-19 caseload over 68 lakh after 78,524 more test positive in past 24 hrs; recovery rate at 85.3%
• 4 years agoThe COVID-19 toll climbed to 1,05,526 on Thursday with 971 people succumbing to the viral infection. The fatality rate stands at 1.54%
India's COVID-19 tally over 66.85 lakh with 61,267 new infections; recovery rate rises to 84.7%
• 4 years agoThe COVID-19 toll climbed to 1,03,569 on Tuesday with 884 people succumbing to the disease in last 24 hours, said the health ministry
Saliva-based COVID-19 diagnosis is cheaper and faster compared to swab testing, say scientists
• 5 years agoDiscussion on the technology intensified after the US FDA authorised the Yale School of Public Health Emergency to use its 'Salivadirect' COVID-19 diagnostic test
Subject Expert Committee seeks DCGI nod to use hepatitis injection in phase 3 trial of COVID-19 vaccine
• 5 years agoSo far, Thymosin @-1 injection 1.6 mg has been used to treat chronic Hepatitis B
India crosses one million COVID-19 cases; toll in world's third-worst affected country over 25,000
• 5 years agoMaharashtra, the state most ravaged by the coronavirus, has registered a total of 2,84,281 COVID-19 cases and 11,194 fatalities
Cipla's remdevisir to cost Rs 4,000 per 100 mg vial in India; pricing among lowest globally: Report
• 5 years agoCipla India business chief executive officer Nikhil Chopra said that the company was launching Cipremi commercially on Wednesday and aims to supply over 80,000 vials within the first month, but did not give details on pricing.
'COVID-19 crisis worse than war of Mahabharata': Shiv Sena targets PM for claiming pandemic would end in 21 days
• 5 years agoThe fight against COVID-19 is more difficult than the mythological war of Mahabharata, said Shiv Sena, adding that the battle against the pandemic will continue till 2021 as the vaccine won't be available before that.